[HTML][HTML] The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention …
A Ghazal, H Shemirani, A Amirpour… - Arya …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Previous studies have proved that intracoronary injection of eptifibatide is
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute …
A Ghazal, H Shemirani, A Amirpour… - ARYA …, 2019 - europepmc.org
Background Previous studies have proved that intracoronary injection of eptifibatide is safe
and more effective in infarct size reduction and clinical outcomes than intravenously …
and more effective in infarct size reduction and clinical outcomes than intravenously …
[PDF][PDF] The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in …
A Ghazal, H Shemirani, A Amirpour… - …, 2019 - pdfs.semanticscholar.org
BACKGROUND: Previous studies have proved that intracoronary injection of eptifibatide is
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute …
A Ghazal, H Shemirani, A Amirpour… - ARYA Atherosclerosis …, 2019 - arya.mui.ac.ir
BACKGROUND: Previous studies have proved that intracoronary injection of eptifibatide is
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute …
A Ghazal, H Shemirani, A Amirpour… - ARYA …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Previous studies have proved that intracoronary injection of eptifibatide is safe
and more effective in infarct size reduction and clinical outcomes than intravenously …
and more effective in infarct size reduction and clinical outcomes than intravenously …
The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute …
A Ghazal, H SHEMIRANI, A Amirpour, AM KERMANI - 2019 - sid.ir
BACKGROUND: Previous studies have proved that intracoronary injection of Eptifibatide is
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute …
A Ghazal, H Shemirani, A Amirpour… - ARYA …, 2019 - arya1.mui.ac.ir
BACKGROUND: Previous studies have proved that intracoronary injection of eptifibatide is
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute …
A Ghazal, H Shemirani, A Amirpour… - ARYA …, 2019 - search.proquest.com
BACKGROUND: Previous studies have proved that intracoronary injection of eptifibatide is
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute …
A Ghazal, H Shemirani, A Amirpour… - ARYA …, 2019 - europepmc.org
Background Previous studies have proved that intracoronary injection of eptifibatide is safe
and more effective in infarct size reduction and clinical outcomes than intravenously …
and more effective in infarct size reduction and clinical outcomes than intravenously …
[PDF][PDF] The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in …
A Ghazal, H Shemirani, A Amirpour… - EDITORIAL BOARD …, 2019 - arya.mui.ac.ir
BACKGROUND: Previous studies have proved that intracoronary injection of eptifibatide is
safe and more effective in infarct size reduction and clinical outcomes than intravenously …
safe and more effective in infarct size reduction and clinical outcomes than intravenously …